Endo International plc (ENDP) PT Raised to $19 at Citi
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/4/2026
- Wall Street ends sharply higher as Waller remarks ease rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Endo International (ENDP): Vasopressin Headlines Likely Worse than Reality - Citi
August 13, 2018 1:30 PM EDTCiti analyst Liav Abraham weighed in on Endo International plc (NASDAQ: ENDP) following news Athenex lanched a compounded Vasopressin. Abraham said the headline is likely worse than reality.
The firm reiterated a Buy rating and price target of $19.00
For an analyst... More
Endo International (ENDP) Weakness on Compounded Vasopressin Launch Bears Watching FDA Action - RBC
August 13, 2018 11:39 AM EDTThe downside in Endo International (NASDAQ: ENDP) (-2.7%) is related to news Athenex (NASDAQ: ATNX) announced that it had launched compounded Vasopressin injection (i.e. Vasostrict) in ready-to-use premix IV bags via Section 503B of the DQSA, RBC... More
RBC Capital Upgrades Endo International plc (ENDP) to Outperform on Cycle Up-Turn
August 13, 2018 4:51 AM EDT(Updated - August 13, 2018 7:15 AM EDT)
(updated to add analyst comments)
RBC Capital analyst Randall Stanicky upgraded Endo International plc (NASDAQ: ENDP) from Sector Perform to Outperform with a price target of $26.00 (from $8.00).
Stanicky said the upgrade is in... More
